Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-11-12

Clinical Trial Update: Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control [NA]

View source ↗

Summary

The clinical trial evaluating brisk walking and regular-intensity exercise for glycemic control in metabolic syndrome and obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Plymouth State University | Conditions: Metabolic Syndrome, Obesity | NA | Status: WITHDRAWN